bpc-157 body protection compound-157 pentadecapeptide gastric juice Peptide (Body Compound) — 10mg BPC-157 10mg | Body Protection

Study 1: Knee pain (2021)

The application seeks approval for chronic weight management in adults with obesity, defined as a body mass index of 30 or above, or overweight at a BMI of 27 or above with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity

The mechanism is different from direct TrkB activation

10.1046/j.1471-4159.2002.00837.x J

Personalized Formulations Compounded with clinically chosen additives Every protocol clinically supervised Physician Overseen Body Composition Scans InBody 970s scans every 8 weeks How GLP-1 Works in the Body WHAT IS GLP-1 THERAPY The Science Behind GLP-1 Receptor Agonists GLP-1 therapy targets a fundamental problem: dysregulation of the hormonal signals that control hunger, fullness, blood sugar, and metabolism

However, its clinical evidence base is minimal compared to cerebrolysin, consisting primarily of animal studies